| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.49 | 0.0007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |